Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis

Inflammatory Bowel Diseases

Volumn 8, Issue 1, 2002, Pages 1-9

  Ina, Kenji ^a   Kusugami, Kazuo ^a   Shimada, Masaaki ^a   Tsuzuki, Tomoyuki ^a   Nishio, Yuji ^a   Binion, David G ^b   Imada, Akira ^a   Ando, Takafumi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chemokine; Cyclosporine A; Neutrophil; T cell; Ulcerative colitis

Indexed keywords

CHEMOKINE; CYCLOSPORIN A; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESALAZINE; MONOCLONAL ANTIBODY; PREDNISOLONE; RECOMBINANT INTERLEUKIN 2; SALAZOSULFAPYRIDINE; STEROID; SUPEROXIDE;

ADULT; ARTICLE; CELL CULTURE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE BIOPSY; LAMINA PROPRIA; LYMPHOCYTE FUNCTION; MALE; MONONUCLEAR CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SCHOOL CHILD; SUPERNATANT; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0036159171     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200201000-00001     Document Type: Article

References (42)

1. Inflammatory bowel disease. First of two parts
2. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
3. Immunology of inflammatory bowel disease: Etiology and pathogenesis
4. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
5. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine
6. Cyclosporine in severe ulcerative colitis refractory to steroid therapy
7. Intravenous cyclosporin in ulcerative colitis: A five-year experience
8. Calcineurin is a common target of cyclophilin-cyclosporin A and FKB-FK506 complexes
9. Chemokines, inflammation and the immune system
10. Tissue destruction by neutrophils
11. Interferon gamma modulates the expression of neutrophil-derived chemokines
12. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT
13. Mast cell-dependent tumor necrosis factor α production participates in allergic gastric inflammation in mice
14. Leukocyte chemotactic activity of cyclophilin
15. Interleukin 8: Cells of origin in inflammatory bowel disease
16. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema
17. Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations
18. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls
19. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease
20. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent
21. Mucosal chemokine activity in Helicobacter pylori infection
22. Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease
23. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in inflammatory bowel disease
24. Troxipide, a novel anti-ulcer compound, has inhibitory effects on human neutrophil migration and activation induced by various stimulants
25. Phenotypic and functional characterization of T-cell lines generated from colonoscopic biopsy specimens in patients with ulcerative colitis
26. Lamina propria mononuclear cells express and respond to interleukin-2 differently in Crohn's disease and ulcerative colitis
27. Interleukin-15 activity in the rectal mucosa of inflammatory bowel disease
28. A simplification of the protein assay method of Lowry et al, which is more generally applicable
29. Mucosal macrophage inflammatory protein-1α activity in Helicobacter pylori infection
30. Helicobacter pylori-associated gastric ulcer exhibits enhanced mucosal chemokine activity at the ulcer site
31. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytototoxic T lymphocytes expressing Leu-7 antigen
32. Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis
33. The mechanism of action of cyclosporin A and FK506
34. Cyclosporin A reduces the severity of cold-restraint-induced gastric lesions: Role of leukocytes
35. Cytokine-induced respiratory burst of human neutrophils: Dependence on extracellular matrix proteins and CD11/CD18 integrins
36. 5-Aminosalicylic acid is a potent inhibitor of interleukin 1β production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease
37. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1α
38. Preliminary report: Cyclosporin in treatment of severe active ulcerative colitis
39. Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29)
40. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A
41. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium
42. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis